Approval · Notice of Compliance 10820 · 2009
TOLOXIN: Notice of Compliance 10820
Issued December 1, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10820
- Date
- December 1, 2009
- Company
- Mm Therapeutics IncMontreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Cardiotonic glycoside